These results indicate that fibroblast-derived paracrine signaling and the secretome promote drug resistance in pNF1 tumor structures by upregulating Pgp, with fibroblasts themselves exhibiting even higher expression levels consistent with their greater resistance in 3D cultures. The gene discussed is PGP; the disease is neoplasm.